OFATUMUMAB WITH IVAC FOR DLBCL PATIENTS WHO FAILED R-CHOP AND WERE NOT CANDIDATES FOR HIGH-DOSE THERAPY AND ASCT - PHASE 2 TRIAL OF THE POLISH LYMPHOMA RESEARCH GROUP (PLRG-8)

2019 ◽  
Vol 37 ◽  
pp. 436-437
Author(s):  
E. Paszkiewicz-Kozik ◽  
W. Michalski ◽  
M. Taszner ◽  
W. Knopińska-Posłuszny ◽  
M. Mordak-Domagała ◽  
...  
Keyword(s):  
Research Group ◽  
High Dose ◽  
Phase 2 ◽  
High Dose Therapy ◽  
Dose Therapy ◽  
Phase 2 Trial

Thalidomide maintenance following high-dose therapy in multiple myeloma: a UK myeloma forum phase 2 study

2007 ◽  
Vol 139 (3) ◽  
pp. 429-433 ◽  
Author(s):  
Sylvia Feyler ◽  
Andy Rawstron ◽  
Graham Jackson ◽  
John A. Snowden ◽  
Kim Cocks ◽  
...  
Keyword(s):  
Multiple Myeloma ◽  
High Dose ◽  
Phase 2 ◽  
High Dose Therapy ◽  
Dose Therapy ◽  
Phase 2 Study

Rituximab combined with DexaBEAM followed by high dose therapy as salvage therapy in patients with relapsed or refractory B-cell lymphoma: mature results of a phase II multicentre study

2014 ◽  
Vol 168 (6) ◽  
pp. 824-834 ◽  
Author(s):  
Sebastian Kirschey ◽  
Thomas Flohr ◽  
Hans H. Wolf ◽  
Norbert Frickhofen ◽  
Martin Gramatzki ◽  
...  
Keyword(s):  
Multicentre Study ◽  
B Cell ◽  
Phase Ii ◽  
Salvage Therapy ◽  
Cell Lymphoma ◽  
B Cell Lymphoma ◽  
High Dose ◽  
High Dose Therapy ◽  
Dose Therapy

scholarly journals The modification of high-dose therapy shortens the duration of neutropaenia by delay of leucocyte nadir

2006 ◽  
Vol 37 (12) ◽  
pp. 1087-1091 ◽  
Author(s):  
T Kiefer ◽  
W H Krüger ◽  
F Schüler ◽  
C Lotze ◽  
C Hirt ◽  
...  
Keyword(s):  
High Dose ◽  
High Dose Therapy ◽  
Dose Therapy

Disposition of total and unbound etoposide following high-dose therapy

1993 ◽  
Vol 32 (4) ◽  
pp. 273-278 ◽  
Author(s):  
Terry L. Schwinghammer ◽  
Ronald A. Fleming ◽  
Craig S. Rosenfeld ◽  
Donna Przepiorka ◽  
Richard K. Shadduck ◽  
...  
Keyword(s):  
High Dose ◽  
High Dose Therapy ◽  
Dose Therapy

106 High-dose therapy with etoposide, ifosfamide, carboplatin, and epirubicin (VIC-E) in non-small cell lung cancer (NSCLC)

Lung Cancer ◽  
1997 ◽  
Vol 18 ◽  
pp. 30
Author(s):  
S. Fetscher ◽  
W. Brugger ◽  
R. Engelhardt ◽  
L. Kanz ◽  
J. Hasse ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
High Dose ◽  
Small Cell Lung ◽  
High Dose Therapy ◽  
Dose Therapy

Angiogenetic Factors and Biochemical Markers of Bone Metabolism in POEMS Syndrome Treated with High-Dose Therapy and Autologous Stem Cell Support

2006 ◽  
Vol 7 (1) ◽  
pp. 73-76 ◽  
Author(s):  
Efstathios Kastritis ◽  
Evangelos Terpos ◽  
Athanasios Anagnostopoulos ◽  
Irini Xilouri ◽  
Meletios Athanasios Dimopoulos
Keyword(s):  
Stem Cell ◽  
Bone Metabolism ◽  
Biochemical Markers ◽  
Poems Syndrome ◽  
High Dose ◽  
High Dose Therapy ◽  
Stem Cell Support ◽  
Dose Therapy ◽  
Cell Support
Sign in / Sign up

Export Citation Format

Share Document